Medicus Pharma Completes Regulation A Offering

Paul, Weiss advised Medicus Pharma Ltd. in its Regulation A offering of units comprised of one common share and one warrant to purchase one common share. Medicus Pharma is a development-stage life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer. Maxim Group LLC acted as the lead placement agent for the offering.

The Paul, Weiss team included corporate partner Christopher Cummings and tax partner Matthew Jordan.